Aptalis Pharma Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APTALIS PHARMA US, and what generic and branded alternatives to APTALIS PHARMA US drugs are available?
APTALIS PHARMA US has one approved drug.
Summary for Aptalis Pharma Us
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Aptalis Pharma Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aptalis Pharma Us | BENTYL | dicyclomine hydrochloride | SYRUP;ORAL | 007961-002 | Oct 15, 1984 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
